Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin McKenzie

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The American Journal of Medicine|November 25, 2010
An uncommon cause of portal hypertension: schistosomiasisStephen P Juraschek, Lora Bankova, Olufunmilayo Falade, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2007
Systemic pharmacokinetics of rifaximin in volunteers with shigellosisDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2006
Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challengeDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Journal of Health, Population, and Nutrition|January 31, 2012
Lactoferrin for the prevention of post-antibiotic diarrhoeaAlison M Laffan, Robin McKenzie, Jennifer Forti, et al.
Vaccine|February 23, 2007
Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge studyRobin McKenzie, A Louis Bourgeois, Sarah A Frech, et al.
Infection and Immunity|January 31, 2007
Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneumGregory M Glenn, Christina P Villar, David C Flyer, et al.
Vaccine|July 8, 2008
A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETECRobin McKenzie, Michael Darsley, Nicola Thomas, et al.
Vaccine|May 28, 2011
A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)Chad K Porter, Mark S Riddle, David R Tribble, et al.
Vaccine|September 24, 2011
Comparative evaluation of the antibody in lymphocyte supernatant (ALS) and enzyme-linked immunospot (ELISPOT) assays for measuring mucosal immune responses to Shigella antigensAndrea J Feller, Robin McKenzie, David N Taylor, et al.
Vaccine|May 13, 2008
Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidateRobin McKenzie, Malabi M Venkatesan, Marcia K Wolf, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The American Journal of Medicine|November 25, 2010
An uncommon cause of portal hypertension: schistosomiasisStephen P Juraschek, Lora Bankova, Olufunmilayo Falade, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2007
Systemic pharmacokinetics of rifaximin in volunteers with shigellosisDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2006
Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challengeDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Journal of Health, Population, and Nutrition|January 31, 2012
Lactoferrin for the prevention of post-antibiotic diarrhoeaAlison M Laffan, Robin McKenzie, Jennifer Forti, et al.
Vaccine|February 23, 2007
Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge studyRobin McKenzie, A Louis Bourgeois, Sarah A Frech, et al.
Infection and Immunity|January 31, 2007
Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneumGregory M Glenn, Christina P Villar, David C Flyer, et al.
Vaccine|July 8, 2008
A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETECRobin McKenzie, Michael Darsley, Nicola Thomas, et al.
Vaccine|May 28, 2011
A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)Chad K Porter, Mark S Riddle, David R Tribble, et al.
Vaccine|September 24, 2011
Comparative evaluation of the antibody in lymphocyte supernatant (ALS) and enzyme-linked immunospot (ELISPOT) assays for measuring mucosal immune responses to Shigella antigensAndrea J Feller, Robin McKenzie, David N Taylor, et al.
Vaccine|May 13, 2008
Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidateRobin McKenzie, Malabi M Venkatesan, Marcia K Wolf, et al.
Pageof 4